Skleo Health is proud to announce a significant funding milestone, having raised 3,000,000 in capital to further its groundbreaking mission in the health-tech sector. As a leading German company dedicated to eliminating preventable blindness, Skleo Health has engineered an innovative platform that redefines accessible preventive care. The funding will be strategically invested in enhancing the state-of-the-art technology that underpins its dual-layer diagnostic approach, which utilizes advanced AI analysis alongside medical validation by licensed ophthalmologists. This seamless integration not only enables partners—ranging from opticians and pharmacies to retail stores and corporations—to provide rapid and accurate eye screenings but also directly connects patients with specialized care, ensuring timely intervention and improved outcomes.
The fresh capital will accelerate research and development initiatives, expand the network of healthcare providers, and further integrate user-friendly digital solutions to streamline patient journeys from early detection to treatment. With a focus on scalability, Skleo Health’s platform is set to redefine how preventive eye care is delivered, ensuring that high-quality screenings are both accessible and affordable throughout the community. This investment underscores the market’s confidence in the company’s ability to disrupt traditional models of healthcare delivery and pave the way for a more efficient, patient-centric system. In addition, the funding will support strategic partnerships and educational campaigns to raise awareness about the importance of regular eye screenings and early detection, setting a new industry standard that prioritizes patient health and overall community wellbeing. To learn more about Skleo Health and its innovative approach, visit www.skleo.de.
